“NeuroQore’s Electromagnetics: A New Way to Treat Depression & Neurobehavioral Disorders” Silicon Valley medical device start-up, NeuroQore Inc., has developed a novel platform technology that it believes can be applied to many neurobehavioral disorders and could provide rapid treatment for major depressive disorder (MDD). The team is striving to put an end to the most devastating of all endings: suicide. In this interview, co-founder and CEO Mehran Talebinejad talks about his experiences in co-founding the company and what’s next for NeuroQore.
Paris-based start-up AblaCare is developing an innovative device and minimally-invasive procedure for the treatment of Polycystic Ovary Syndrome (PCOS) related infertility which they believe would be less risky, less invasive, and less costly than current solutions. In this candid interview filmed onsite at MedTech Strategist’s Innovation Summit Dublin, Ireland with Analyst Kayleen Brown, CEO Anne Osdoit and COO Marion Gasperment talk about their current priorities and their experiences so far on their start-up journey.